Invention Grant
- Patent Title: Compounds suitable for treatment of haemophilia
- Patent Title (中): 适合治疗血友病的化合物
-
Application No.: US13916262Application Date: 2013-06-12
-
Publication No.: US09125890B2Publication Date: 2015-09-08
- Inventor: Gert Bolt , Ditte Maria Karpf , Frederik Rode , Jesper Haaning , Kirstine Roepstorff , Lars Thim , Maj Petersen , Marianne Kjalke , Ole Hvilsted Olsen , Jens Jacob Hansen , Christian Rischel
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Nonna G. Akopyan
- Priority: EP12165301 20120424; EP13150576 20130109
- Main IPC: C07K14/755
- IPC: C07K14/755 ; A61K38/37 ; A61K9/00
Abstract:
The present invention relates to Von Willebrand (VWF) compounds as well as compositions suitable for treatment of blood clotting diseases. The present invention also relates to pharmaceutical compositions, freeze-dried or liquid, comprising (i) a Factor VIII molecule and (ii) a VWF compound.
Public/Granted literature
- US20140018297A1 COMPOUNDS SUITABLE FOR TREATMENT OF HAEMOPHILIA Public/Granted day:2014-01-16
Information query
